Search Within

Heiko Schoder

  1. "David Straus"
Formats
  1. Meeting Abstract (34)
  2. Journal Article (22)
Groups
  1. Center for Hematologic Malignancies (56)
  2. Department of Medicine (56)
  3. Hematologic Malignancies, Division of (56)
  4. Lymphoma (56)
  5. Molecular Imaging and Therapy Service (56)
  6. Radiology, Department of (56)

More Groups

People
  1. David Straus (56)
  2. Andrew Zelenetz (44)
  3. Matthew Matasar (40)
  4. Paul Hamlin (40)
  5. Alison Moskowitz (39)
  6. Ariela Noy (39)

More People

Years
  1. 2024 (2)
  2. 2023 (4)
  3. 2022 (4)
  4. 2021 (8)
  5. 2020 (3)
  6. 2019 (5)

More Years

Publications
  1. Blood (28)
  2. Hematological Oncology (8)
  3. Journal of Clinical Oncology (7)
  4. Haematologica (4)
  5. American Journal of Hematology (1)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (29)
  2. Wiley Blackwell (8)
  3. American Society of Clinical Oncology (7)
  4. Ferrata Storti Foundation (4)
  5. American Association for Cancer Research (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (56)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET
    Meeting Abstract

    Moskowitz, C. H.; Schoder, H.; Hamlin, P. A.; Gerecitano, J. F.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M.; Portlock, C. S.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: Pretreatment prognostic factors and interim PET
    Journal Article

    Straus, D. J.; Johnson, J. L.; LaCasce, A. S.; Bartlett, N. L.; Kostakoglu, L.; Hsi, E. D.; Schoder, H.; Hall, N. C.; Jung, S. H.; Canellos, G. P.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma
    Journal Article

    Moskowitz, C. H.; Schoder, H.; Teruya-Feldstein, J.; Sima, C.; Iasonos, A.; Portlock, C. S.; Straus, D.; Noy, A.; Palomba, M. L.; O'Connor, O. A.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Validation of the international harmonization project (IHP) guidelines in early stage Hodgkin lymphoma (HL) treated with adriamycin, vinblastine and gemcitabine (AVG) (CALGB 50203): Early results
    Meeting Abstract

    Kostakoglu, L.; Straus, D. J.; Schoder, H.; LaCasce, A. S.; Bartlett, N. L.; Hall, N.; Johnson, J. L.; Jung, S. H.; Canellos, G. P.; Schwartz, L. H.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL
    Meeting Abstract

    Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
    Blood (2006)

    Fulltext@MSK | Save